Insights into atherosclerosis therapy in antiphospholipid syndrome
- 1 November 2007
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 7 (1) , 46-51
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemiaJournal of Autoimmunity, 2007
- Antiphospholipid antibodies: Lessons from the benchJournal of Autoimmunity, 2007
- Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factorsAutoimmunity Reviews, 2006
- Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with β2-glycoprotein-I and anti-β2-glycoprotein-I antibodiesAutoimmunity Reviews, 2006
- Inflammation: A pivotal link between autoimmune diseases and atherosclerosisAutoimmunity Reviews, 2006
- Accelerated atherosclerosis, immune response and autoimmune rheumatic diseasesAutoimmunity Reviews, 2006
- Characterization of monoclonal anti-β2-glycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndromeJournal of Autoimmunity, 2006
- Antiphospholipid syndrome: pathogenic mechanismsAutoimmunity Reviews, 2003
- Antiphospholipid antibodies and myocardial infarctionLupus, 1998
- Age-specific Incidence Rates of Myocardial Infarction and Angina in Women with Systemic Lupus Erythematosus: Comparison with the Framingham StudyAmerican Journal of Epidemiology, 1997